Literature DB >> 23571119

Drug-evoked synaptic plasticity: beyond metaplasticity.

Meaghan C Creed1, Christian Lüscher.   

Abstract

Addictive drugs such as cocaine induce synaptic plasticity in the ventral tegmental area and its projection areas, which may represent the cellular correlate of an addiction trace. Cocaine induces changes in excitatory transmission primarily in the VTA, which persists for days after a single exposure. These initial alterations in synaptic transmission represent a metaplasticity that is permissive for late stages of remodeling throughout the mesocorticolimbic circuitry, specifically in the NAc. Specific synaptic and cellular changes in the NAc persist following prolonged exposure to cocaine, and this remodeling may contribute to altered behavior. By manipulating synaptic activity in the NAc, it may be possible to reverse pathological synaptic transmission and its associated abnormal behavior following exposure to addictive drugs.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23571119     DOI: 10.1016/j.conb.2013.03.005

Source DB:  PubMed          Journal:  Curr Opin Neurobiol        ISSN: 0959-4388            Impact factor:   6.627


  17 in total

Review 1.  The neural rejuvenation hypothesis of cocaine addiction.

Authors:  Yan Dong; Eric J Nestler
Journal:  Trends Pharmacol Sci       Date:  2014-06-20       Impact factor: 14.819

Review 2.  Levodopa-induced plasticity: a double-edged sword in Parkinson's disease?

Authors:  Paolo Calabresi; Veronica Ghiglieri; Petra Mazzocchetti; Ilenia Corbelli; Barbara Picconi
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-07-05       Impact factor: 6.237

Review 3.  Silent Synapses Speak Up: Updates of the Neural Rejuvenation Hypothesis of Drug Addiction.

Authors:  Yanhua H Huang; Oliver M Schlüter; Yan Dong
Journal:  Neuroscientist       Date:  2015-03-31       Impact factor: 7.519

Review 4.  Molecular mechanisms of synaptic remodeling in alcoholism.

Authors:  Evan J Kyzar; Subhash C Pandey
Journal:  Neurosci Lett       Date:  2015-01-23       Impact factor: 3.046

5.  Chronic ethanol exposure increases inhibition of optically targeted phasic dopamine release in the nucleus accumbens core and medial shell ex vivo.

Authors:  James R Melchior; Sara R Jones
Journal:  Mol Cell Neurosci       Date:  2017-09-20       Impact factor: 4.314

6.  Kappa opioid receptor modulation of excitatory drive onto nucleus accumbens fast-spiking interneurons.

Authors:  Benjamin C Coleman; Kevin M Manz; Brad A Grueter
Journal:  Neuropsychopharmacology       Date:  2021-08-16       Impact factor: 7.853

7.  Spike timing-dependent plasticity at GABAergic synapses in the ventral tegmental area.

Authors:  Jayaraj N Kodangattil; Matthieu Dacher; Michael E Authement; Fereshteh S Nugent
Journal:  J Physiol       Date:  2013-07-29       Impact factor: 5.182

Review 8.  Habitual Alcohol Seeking: Neural Bases and Possible Relations to Alcohol Use Disorders.

Authors:  Laura H Corbit; Patricia H Janak
Journal:  Alcohol Clin Exp Res       Date:  2016-05-25       Impact factor: 3.455

Review 9.  Cell-type and projection-specific dopaminergic encoding of aversive stimuli in addiction.

Authors:  Kimberly C Thibeault; Munir Gunes Kutlu; Christina Sanders; Erin S Calipari
Journal:  Brain Res       Date:  2018-12-20       Impact factor: 3.252

10.  Reinstatement of synaptic plasticity in the aging brain through specific dopamine transporter inhibition.

Authors:  Jana Lubec; Predrag Kalaba; Ahmed M Hussein; Daniel Daba Feyissa; Mohamed H Kotob; Rasha R Mahmmoud; Oliver Wieder; Arthur Garon; Claudia Sagheddu; Marija Ilic; Vladimir Dragačević; Anita Cybulska-Klosowicz; Martin Zehl; Judith Wackerlig; Simone B Sartori; Karl Ebner; Shima Kouhnavardi; Alexander Roller; Natalie Gajic; Marco Pistis; Nicolas Singewald; Johann Jakob Leban; Volker Korz; Jovana Malikovic; Roberto Plasenzotti; Harald H Sitte; Francisco J Monje; Thierry Langer; Ernst Urban; Christian Pifl; Gert Lubec
Journal:  Mol Psychiatry       Date:  2021-12       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.